Abstract
The lack of reliable translational procedures applicable to both patients and experimental models are a major obstacle for the advancement of basic research as well as for the development of therapeutics. This is particularly relevant to neurodegenerative disorders such as AD (Alzheimer's disease), where the predictive validity of animal models and procedures applied preclinically have met with little success. Two approaches available for human diagnostics are currently experiencing major advancements in preclinical research: in vivo imaging using MRI (magnetic resonance imaging) or PET (positron-emission tomography) and recordings of brain electrical activity via surface EEG (electroencephalogram). The present paper reviews the results obtained so far in rodent AD models, and summarizes advantages and disadvantages of such procedures.
| Original language | English |
|---|---|
| Pages (from-to) | 874-880 |
| Number of pages | 7 |
| Journal | Biochemical Society Transactions |
| Volume | 39 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer's disease (AD)
- Imaging
- Positron-emission tomography (PET)
- Power spectrum
- Quantitative electroencephalogram
- Sleep
Fingerprint
Dive into the research topics of 'FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS